Contact Ludwig Gold
Miracor Medical Systems has developed a unique and potentially disruptive technology, PICSO® (Pressure-controlled Intermittent Coronary Sinus Occlusion), for acute coronary syndrome (ACS) and – at a later stage – heart failure patients.
The technology is based on the intermittent occlusion of the coronary sinus that empties the majority of the blood from the heart tissue (‘myocardium’). The mode of action is well-documented and has been developed over decades in cardiovascular applications such as retrograde coronary sinus cardioplegia in cardiac surgery. Miracor is now applying this knowledge for severe heart attack patients in interventional cardiology.